Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W F Wilson

Showing results (51-60 of 391) with videos related to

Pageof 40
Sort By:
Clinical Chemistry|March 2, 2012
A message from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IVHubert W Vesper, Peter W F Wilson, Nader Rifai
Circulation|June 11, 2008
Beyond established and novel risk factors: lifestyle risk factors for cardiovascular diseaseDariush Mozaffarian, Peter W F Wilson, William B Kannel
Circulation|June 16, 2004
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?Paul M Ridker, Peter W F Wilson, Scott M Grundy
Metabolic Syndrome and Related Disorders|March 29, 2008
Cardiovascular risk and the metabolic syndromeMartin K Rutter, James B Meigs, Peter W F Wilson
The American Journal of Medicine|May 5, 2009
Obesity: why be concerned?W Virgil Brown, Ken Fujioka, Peter W F Wilson, et al.
American Heart Journal|June 25, 2004
Concept and usefulness of cardiovascular risk profilesWilliam B Kannel, Ralph B D'Agostino, Lisa Sullivan, et al.
Journal of the American Society of Hypertension : JASH|August 12, 2015
Antecedent blood pressure as a predictor of cardiovascular diseaseAnthony Bonifonte, Turgay Ayer, Emir Veledar, et al.
American Heart Journal|March 1, 2006
Clinical trial issues in weight-loss therapyManesh R Patel, Mark Donahue, Peter W F Wilson, et al.
Diabetes Care|February 28, 2004
The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart StudyCaroline S Fox, Lisa Sullivan, Ralph B D'Agostino, et al.
Diabetes Care|September 28, 2002
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring StudyJames B Meigs, David M Nathan, Ralph B D'Agostino, et al.
Pageof 40

Showing results (51-60 of 391) with videos related to

Sort By:
Pageof 40
Clinical Chemistry|March 2, 2012
A message from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IVHubert W Vesper, Peter W F Wilson, Nader Rifai
Circulation|June 11, 2008
Beyond established and novel risk factors: lifestyle risk factors for cardiovascular diseaseDariush Mozaffarian, Peter W F Wilson, William B Kannel
Circulation|June 16, 2004
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?Paul M Ridker, Peter W F Wilson, Scott M Grundy
Metabolic Syndrome and Related Disorders|March 29, 2008
Cardiovascular risk and the metabolic syndromeMartin K Rutter, James B Meigs, Peter W F Wilson
The American Journal of Medicine|May 5, 2009
Obesity: why be concerned?W Virgil Brown, Ken Fujioka, Peter W F Wilson, et al.
American Heart Journal|June 25, 2004
Concept and usefulness of cardiovascular risk profilesWilliam B Kannel, Ralph B D'Agostino, Lisa Sullivan, et al.
Journal of the American Society of Hypertension : JASH|August 12, 2015
Antecedent blood pressure as a predictor of cardiovascular diseaseAnthony Bonifonte, Turgay Ayer, Emir Veledar, et al.
American Heart Journal|March 1, 2006
Clinical trial issues in weight-loss therapyManesh R Patel, Mark Donahue, Peter W F Wilson, et al.
Diabetes Care|February 28, 2004
The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart StudyCaroline S Fox, Lisa Sullivan, Ralph B D'Agostino, et al.
Diabetes Care|September 28, 2002
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring StudyJames B Meigs, David M Nathan, Ralph B D'Agostino, et al.
Pageof 40